Richard Dolinar

428 citations
14 papers · 339 indexed · h-index 9
Topics
Biosimilars and Bioanalytical Methods (7 papers)Pharmaceutical Economics and Policy (5 papers)Diabetes and associated disorders (3 papers)

In The Last Decade

Richard Dolinar

13 papers receiving 311 citations

Peers

Richard Dolinar
Comparison fields: 5 of 58
  • Endocrinology, Diabetes and Metabolism 214
  • Genetics 197
  • Surgery 188
  • Immunology 81
  • Economics and Econometrics 59
Replace Marek Wardęcki with:
Marek Wardęcki United States
Jessica Hicks United States
Amitabh Sharma United Kingdom
Mahtab Sharifi United Kingdom
Jennifer A. Klinke Canada
Susanne M. Gauthier United States
Marcus J. Lyall United Kingdom
Janne Pott Germany
Donald R McClellan United States
Robin J. Edison United States
Richard Dolinar relative to Marek Wardęcki United States Marek Wardęcki's profile →
Citations per field
00.5×8.4×
Marek Wardęcki · 1×
Citations per year

Countries citing papers authored by Richard Dolinar

Since Specialization
Citations

This map shows the geographic impact of Richard Dolinar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Dolinar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Dolinar more than expected).

Fields of papers citing papers by Richard Dolinar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Dolinar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Dolinar. The network helps show where Richard Dolinar may publish in the future.

Co-authorship network of co-authors of Richard Dolinar

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Dolinar. A scholar is included among the top collaborators of Richard Dolinar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Dolinar. Richard Dolinar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 23
2 8
3 2
4 39
5 11
6 2
7 8
8 17
9 4
10 3
11 94
12 9
13
Anti-thymocyte globulin and prednisone immunotherapy of recent onset type 1 diabetes mellitus.
107
14 12

About Richard Dolinar

Richard Dolinar is a scholar working on Immunology, Economics and Econometrics and Endocrinology, Diabetes and Metabolism, having authored 14 papers that have together received 339 indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (7 papers), Pharmaceutical Economics and Policy (5 papers) and Diabetes and associated disorders (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (214 citations), Genetics (197 citations) and Surgery (188 citations). Richard Dolinar has collaborated with scholars based in United States, Australia and Netherlands. Frequent co-authors include R. A. JACKSON, S. Srikanta, Tsuyoshi Aoki, Steven L. Rabinowe, George S. Eisenbarth, Harold Starkman, Pnina Vardi, Laura Crisá, J. Stuart Soeldner and Raymonde D Herskowitz. Their work appears in journals such as JAMA, Endocrinology and Diabetologia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026